Proteomic analysis of HCV cirrhosis and HCV-induced HCC

Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation

Valeria Mas, Daniel Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background.: Progression from chronic hepatitis C virus (HCV) infection to cirrhosis and hepatocellular carcinoma (HCC) results in protein changes in the peripheral blood. We evaluated global protein expression in plasma samples of HCV-cirrhotic and HCV-cirrhotic-HCC patients. Patients and Methods.: Plasma samples from 25 HCV-cirrhotic-HCC and 10 HCV-cirrhotic patients were quantitatively evaluated for protein expression. Tryptic peptides were analyzed using Thermo linear ion-trap mass spectrometer (LTQ) coupled with a Surveyor HPLC system (Thermo). SEQUEST and X!Tandem database search algorithms were used for peptide sequence identification. Protein relative quantification was performed using the area under the curve from the select ion chromatogram. A significant fold change between groups was based on controlling the false discovery rate (FDR) at less than 5%. Results.: We identified and quantified 2320 proteins from the analysis of the different protein pattern between HCV-cirrhosis and HCV-HCC samples. Gene ontology terms classified the more important biologic process related to these proteins as signal transduction, regulation of transcription DNA-dependent, protein amino acid phosphorylation, cell adhesion, transport, and immune response. Seven proteins showed significant expression changes with a FDR less than 5% between cirrhosis and tumor groups. Moreover, 18 proteins showed significant expression changes (FDR <5%) when plasma samples from HCV-cirrhosis were compared with early HCV-HCC. Conclusions.: Differential protein expression was observed between samples from HCV patients with cirrhosis with and without HCC. Also, differences were observed between early and advanced HCV-HCC samples. This study provides important information for discovery of potential biomarkers for early HCC diagnosis in HCV cirrhotic patients.

Original languageEnglish (US)
Pages (from-to)143-152
Number of pages10
JournalTransplantation
Volume87
Issue number1
DOIs
StatePublished - Jan 15 2009

Fingerprint

Hepacivirus
Liver Transplantation
Proteomics
Hepatocellular Carcinoma
Fibrosis
Biomarkers
Proteins
Ions
Peptides
Gene Ontology
Chronic Hepatitis C
Virus Diseases
Cell Adhesion
Area Under Curve
Signal Transduction
High Pressure Liquid Chromatography
Phosphorylation
Databases
Amino Acids

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Proteomic analysis of HCV cirrhosis and HCV-induced HCC : Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. / Mas, Valeria; Maluf, Daniel; Archer, Kellie J.; Yanek, Kenneth; Bornstein, Karen; Fisher, Robert A.

In: Transplantation, Vol. 87, No. 1, 15.01.2009, p. 143-152.

Research output: Contribution to journalArticle

@article{fdb52fbad9be4a0f9cde35d27338dabb,
title = "Proteomic analysis of HCV cirrhosis and HCV-induced HCC: Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation",
abstract = "Background.: Progression from chronic hepatitis C virus (HCV) infection to cirrhosis and hepatocellular carcinoma (HCC) results in protein changes in the peripheral blood. We evaluated global protein expression in plasma samples of HCV-cirrhotic and HCV-cirrhotic-HCC patients. Patients and Methods.: Plasma samples from 25 HCV-cirrhotic-HCC and 10 HCV-cirrhotic patients were quantitatively evaluated for protein expression. Tryptic peptides were analyzed using Thermo linear ion-trap mass spectrometer (LTQ) coupled with a Surveyor HPLC system (Thermo). SEQUEST and X!Tandem database search algorithms were used for peptide sequence identification. Protein relative quantification was performed using the area under the curve from the select ion chromatogram. A significant fold change between groups was based on controlling the false discovery rate (FDR) at less than 5{\%}. Results.: We identified and quantified 2320 proteins from the analysis of the different protein pattern between HCV-cirrhosis and HCV-HCC samples. Gene ontology terms classified the more important biologic process related to these proteins as signal transduction, regulation of transcription DNA-dependent, protein amino acid phosphorylation, cell adhesion, transport, and immune response. Seven proteins showed significant expression changes with a FDR less than 5{\%} between cirrhosis and tumor groups. Moreover, 18 proteins showed significant expression changes (FDR <5{\%}) when plasma samples from HCV-cirrhosis were compared with early HCV-HCC. Conclusions.: Differential protein expression was observed between samples from HCV patients with cirrhosis with and without HCC. Also, differences were observed between early and advanced HCV-HCC samples. This study provides important information for discovery of potential biomarkers for early HCC diagnosis in HCV cirrhotic patients.",
author = "Valeria Mas and Daniel Maluf and Archer, {Kellie J.} and Kenneth Yanek and Karen Bornstein and Fisher, {Robert A.}",
year = "2009",
month = "1",
day = "15",
doi = "10.1097/TP.0b013e318191c68d",
language = "English (US)",
volume = "87",
pages = "143--152",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Proteomic analysis of HCV cirrhosis and HCV-induced HCC

T2 - Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation

AU - Mas, Valeria

AU - Maluf, Daniel

AU - Archer, Kellie J.

AU - Yanek, Kenneth

AU - Bornstein, Karen

AU - Fisher, Robert A.

PY - 2009/1/15

Y1 - 2009/1/15

N2 - Background.: Progression from chronic hepatitis C virus (HCV) infection to cirrhosis and hepatocellular carcinoma (HCC) results in protein changes in the peripheral blood. We evaluated global protein expression in plasma samples of HCV-cirrhotic and HCV-cirrhotic-HCC patients. Patients and Methods.: Plasma samples from 25 HCV-cirrhotic-HCC and 10 HCV-cirrhotic patients were quantitatively evaluated for protein expression. Tryptic peptides were analyzed using Thermo linear ion-trap mass spectrometer (LTQ) coupled with a Surveyor HPLC system (Thermo). SEQUEST and X!Tandem database search algorithms were used for peptide sequence identification. Protein relative quantification was performed using the area under the curve from the select ion chromatogram. A significant fold change between groups was based on controlling the false discovery rate (FDR) at less than 5%. Results.: We identified and quantified 2320 proteins from the analysis of the different protein pattern between HCV-cirrhosis and HCV-HCC samples. Gene ontology terms classified the more important biologic process related to these proteins as signal transduction, regulation of transcription DNA-dependent, protein amino acid phosphorylation, cell adhesion, transport, and immune response. Seven proteins showed significant expression changes with a FDR less than 5% between cirrhosis and tumor groups. Moreover, 18 proteins showed significant expression changes (FDR <5%) when plasma samples from HCV-cirrhosis were compared with early HCV-HCC. Conclusions.: Differential protein expression was observed between samples from HCV patients with cirrhosis with and without HCC. Also, differences were observed between early and advanced HCV-HCC samples. This study provides important information for discovery of potential biomarkers for early HCC diagnosis in HCV cirrhotic patients.

AB - Background.: Progression from chronic hepatitis C virus (HCV) infection to cirrhosis and hepatocellular carcinoma (HCC) results in protein changes in the peripheral blood. We evaluated global protein expression in plasma samples of HCV-cirrhotic and HCV-cirrhotic-HCC patients. Patients and Methods.: Plasma samples from 25 HCV-cirrhotic-HCC and 10 HCV-cirrhotic patients were quantitatively evaluated for protein expression. Tryptic peptides were analyzed using Thermo linear ion-trap mass spectrometer (LTQ) coupled with a Surveyor HPLC system (Thermo). SEQUEST and X!Tandem database search algorithms were used for peptide sequence identification. Protein relative quantification was performed using the area under the curve from the select ion chromatogram. A significant fold change between groups was based on controlling the false discovery rate (FDR) at less than 5%. Results.: We identified and quantified 2320 proteins from the analysis of the different protein pattern between HCV-cirrhosis and HCV-HCC samples. Gene ontology terms classified the more important biologic process related to these proteins as signal transduction, regulation of transcription DNA-dependent, protein amino acid phosphorylation, cell adhesion, transport, and immune response. Seven proteins showed significant expression changes with a FDR less than 5% between cirrhosis and tumor groups. Moreover, 18 proteins showed significant expression changes (FDR <5%) when plasma samples from HCV-cirrhosis were compared with early HCV-HCC. Conclusions.: Differential protein expression was observed between samples from HCV patients with cirrhosis with and without HCC. Also, differences were observed between early and advanced HCV-HCC samples. This study provides important information for discovery of potential biomarkers for early HCC diagnosis in HCV cirrhotic patients.

UR - http://www.scopus.com/inward/record.url?scp=58949103709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949103709&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e318191c68d

DO - 10.1097/TP.0b013e318191c68d

M3 - Article

VL - 87

SP - 143

EP - 152

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -